BSE filing, NSE: KALPATARU. Summary written from the filing by ALFA Finder's alert engine.
Kalpataru Ltd: key numbers
- Share price
- ₹245.70
- Market cap
- ₹5,060 Cr
- Revenue (annual)
- ₹3,480 Cr
- Net profit (annual)
- ₹93.71 Cr
- P/E (TTM)
- 43.4×Sector 33.7×
- Promoter holding
- 81.33%-0.01% QoQ
- FII holding
- 5.91%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kalpataru Ltd
All →Kalpataru Board Meeting Date
Kalpataru Ltd scheduled its Board meeting for 29 Oct 2026 to consider Q2 and H1 2026 financial results. No decision has been taken yet.
Kalpataru Other Announcement
Kalpataru Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations. The filing reports updated promoter group holdings.
Kalpataru Legal & Regulatory
Kalpataru Limited's subsidiary, Kalpataru Properties, received a GST show-cause notice for ₹73.85 Crore. The company considers the demand unsustainable and expects no material financial impact.
- Value
- ₹73.85 Cr
Kalpataru Other Announcement
Kalpataru Ltd has filed the certificate pursuant to Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026.
Kalpataru Business Update
Kalpataru Limited reported provisional H1 FY27 pre-sales of Rs. 2,587 Crore and collections of Rs. 2,554 Crore, and announced the launch of project Kalpataru Elaara.
Kalpataru Legal & Regulatory
Kalpataru Limited's subsidiary, Ananta Landmarks Private Limited, received a Rs. 14.00 Crore GST show cause notice. The company intends to contest the demand for FY 2022-23.
- Value
- ₹14.00 Cr
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date